mySugr’s 10-year anniversary
Vienna is probably best known for its coffee house culture, empress Sisi, or the rich tradition in art and music - and for more than 10 years as the home of one of the most popular diabetes management apps. In 2012, Frank Westermann, Fredrik Debong, Gerald Stangl, and Michael Forisch founded mySugr and launched the first version of the mySugr app. What began as a start-up with a handful of employees, has grown into a global company that became part of Roche in 2017, supporting people with diabetes all over the world managing their diabetes. Today, the mySugr app has more than 4 million registered users worldwide and is available in over 80 countries and 24 languages.
As one of the four founders, Michael Forisch, Global Head of Digital Quality and Regulatory at Roche Diabetes Care, knows mySugr like the back of his hand. To mark the special occasion, Michael answers ten questions reflecting on the past decade.
Evolution of the mySugr app: 2012 vs 2022 ©2022 mySugr GmbH
mySugr and Roche
5. What reasons brought mySugr and Roche together in 2017?
In 2017, driving a startup out of Vienna into the global market was a very difficult task. We were looking for an established partner to help us make that happen. As Roche was already a mySugr partner since 2014/2015, we were hoping to open a new chapter together in our book and provide our services on a global scale. The vision and values aligned very well. We had a shared mindset and goal to improve and increasingly personalise solutions for people managing diabetes. What we have gained from this new chapter in 2017 has been overwhelmingly valuable and fruitful for everyone.
6. How have mySugr and Roche grown together since 2017? Any key milestones you can highlight?
mySugr is the main patient-facing digital solution of Roche Diabetes Care. It has a fresh look and feel designed to provide a positive experience for users. As such mySugr is the entry door for our digital patients. We looked for ways to open this door to as many people with diabetes as possible. Some of the highlights from the last years:
1) We enabled the connection of mySugr to the RocheDiabetes Care Platform, which provides healthcare professionals with a comprehensive overview of all the data a patient has collected in the mySugr app.
2) In 2018, Roche signed a collaboration agreement with NovoNordisk and mySugr enabled the integration of insulin data from the Novo Nordisk smart insulin pens into the mySugr app. Eli Lilly is also a partner since 2021.
3) One of our joint key milestones was also the launch of the mySugr Pump Control in 2021, allowing users to manage their Accu-Chek Insight pump directly from the smartphone.
But we have not only grown together in terms of providing connected diabetes management solutions. There were many learning processes we went through and many challenging ones included of course. I speak for myself when I say that this joint journey has helped me to grow a lot, personally and professionally.
We have closed the loop and broadened our services to provide access to our solutions for all people with diabetes in the world.
Read more about mySugr and Roche in this article.